Graph Therapeutics vs Pixelgen Technologies

Graph Therapeutics vs Pixelgen Technologies, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Graph Therapeutics is on 44/100 and Pixelgen Technologies on 62/100.

Graph Therapeutics logo
Graph TherapeuticsDeveloping precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.
Try Graph Therapeutics
Pixelgen Technologies logo
Pixelgen TechnologiesA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Try Pixelgen Technologies

Where each one leads

Graph Therapeutics

Leads on none of the measures we hold for both companies.

Pixelgen Technologies

  • our overall score: 62/100 against 44/100
  • agent readiness: 49/100 against 41/100
  • domain rating: 32/100 against 27/100
  • funding raised: $43.5M against $5.0M
  • LinkedIn following: 7,769 against 2,302

At a glance

MeasureGraph TherapeuticsPixelgen Technologies
What it isDeveloping precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
CategoryBiotechnology, Artificial Intelligence, Healthcare, Drug DiscoveryBiotechnology, Life Sciences, Genomics, Proteomics
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20212020
HeadquartersBoston, AustriaStockholm, Sweden
StatusActiveActive

Size, funding and growth

MeasureGraph TherapeuticsPixelgen Technologies
EmployeesNot published45
Total funding$5.0M$43.5M
Latest roundFunding RoundSeries B
LinkedIn followers2,3027,769

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureGraph TherapeuticsPixelgen Technologies
StartupHub scoreOur 0-100 rating44/10062/100
Traction33/10055/100
TeamNot published90/100
Search visibility42/10022/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteD (41/100)D (49/100)
Domain ratingLink authority, 0-10027/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureGraph TherapeuticsPixelgen Technologies
CMSFramerWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4, Google Tag Manager

Graph Therapeutics vs Pixelgen Technologies: common questions

Which is better, Graph Therapeutics or Pixelgen Technologies?

On our 0-100 score Pixelgen Technologies rates higher (62/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do Graph Therapeutics and Pixelgen Technologies compare on the numbers?

Pixelgen Technologies leads on our overall score (62/100 against 44/100), agent readiness (49/100 against 41/100), domain rating (32/100 against 27/100), funding raised ($43.5M against $5.0M), LinkedIn following (7,769 against 2,302).

Read the full Graph Therapeutics review and pricing or the Pixelgen Technologies review and pricing. You can also browse other Graph Therapeutics alternatives we track.